Netherlands
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -39.70 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
2 |
USD -102.80 M
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
3 |
USD -141.24 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
4 |
USD -146.19 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
5 |
USD -464.14 M
|
Dec. 31, 2023 | USD 667.09 | 1.81% |
|
Netherlands |
The Vaccines company in Netherlands with the highest Free Cash Flow is LAVA Therapeutics N.V. (NasdaqGS: LVTX) at USD -39.70 M.
The Vaccines company in Netherlands with the lowest Free Cash Flow is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD -464.14 M.
The top 10 Vaccines companies in Netherlands by Free Cash Flow are LAVA Therapeutics N.V., Pharvaris N.V., NewAmsterdam Pharma Company N.V., Merus N.V. and argenx SE.
The bottom 10 Vaccines companies in Netherlands by Free Cash Flow are argenx SE, Merus N.V., NewAmsterdam Pharma Company N.V., Pharvaris N.V. and LAVA Therapeutics N.V..